Last Posted: Mar 19, 2020
- Re-evaluating the first-tier status of fragile X testing in neurodevelopmental disorders.
Borch Lauren A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Mar - Perceived utility of biological testing for autism spectrum disorder is associated with child and family functioning.
Yusuf Afiqah et al. Research in developmental disabilities 2020 Feb 100103605 - Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
Husson Thomas et al. Translational psychiatry 2020 Feb 10(1) 77 - Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary Mazhor et al. Omics : a journal of integrative biology 2020 Feb - Identification of newborns at risk for autism using electronic medical records and machine learning.
Rahman Rayees et al. European psychiatry : the journal of the Association of European Psychiatrists 2020 Feb 63(1) e22 - Towards the automatic detection of social biomarkers in autism spectrum disorder: introducing the simulated interaction task (SIT)
H Drimalla et al, NPJ Digital Medicine, February 27, 2020 - Towards developing a practical artificial intelligence tool for diagnosing and evaluating autism spectrum disorder: A study using multicenter ABIDE II datasets.
Lu Long et al. JMIR medical informatics 2020 Feb - Association of Genetic Risks With Autism Spectrum Disorder and Early Neurodevelopmental Delays Among Children Without Intellectual Disability.
Takahashi Nagahide et al. JAMA network open 2020 Feb 3(2) e1921644 - Fragile X syndrome: clinical presentation, pathology and treatment.
Salcedo-Arellano María Jimena et al. Gaceta medica de Mexico 2020 156(1) 60-66 - Recent ultra-rare inherited mutations identify novel autism candidate risk genes
AB Wilfert et al, BIORXIV preprints, February 11, 2020
.png)
No hay comentarios:
Publicar un comentario